Breaking News on Contract Research, Manufacturing & Clinical Trials

Outsourcing about cost reduction more than anything else says Deloitte

02-Oct-2015 - Drug companies still outsource to make fixed costs variable rather than to try and improve their public profiles through sustainable sourcing according to a Deloitte analyst.

Vetter pledges €300m to prep network for pharma's future needs

01-Oct-2015 - Pharma M&A, complex APIs and an increasing need for flexibility are driving a €300m manufacturing network overhaul, says Vetter.

Johnson Matthey to take on all Pharmorphix staff

Johnson Matthey buys Sigma-Aldrich solid state chem unit to boost API business

01-Oct-2015 - Johnson Matthey has bought Sigma-Aldrich’s Pharmorphix division to add a 'significant' customer base and expand its European API business.

‘First liquid aspirin’ maker seeks licensing deal

01-Oct-2015 - Innovate Pharmaceuticals has launched what it claims is the world’s first shelf-stable liquid aspirin, and says it is on the look-out for a licensing partner for the “$500m” market.

Pharmas factor green considerations into sourcing decisions say experts

30-Sep-2015 - Drug companies still outsource to cut costs but environmental concerns and therefore contractors’ green credentials are increasingly important say industry experts. 

Catalloy fined after explosion at metal catalysts plant

29-Sep-2015 - A UK supplier of metal catalysts to the drug industry has been fined after an explosion at its site in Widnes left an employee with minor injuries.

Novartis extends Unilife deal for drug delivery device

29-Sep-2015 - Novartis has extended a deal with Unilife for the supply of an injectable drug delivery system for use with an early stage drug candidate.

Lonza's stem cell production insight a boon to innovation and business

28-Sep-2015 - Investments in manufacturing and science have left Lonza well placed to cope with skyrocketing demand for stem cell manufacturing, the CMO says.

Evonik hikes up pharma excipient prices

28-Sep-2015 - Increasing QbD needs and a range of technical service centres have driven up the prices of Evonik’s drug delivery excipient portfolio, the company says.

Mayne starts work on contracting plant and relocates distribution ops

25-Sep-2015 - Mayne Pharma has started adding contract manufacturing capacity at its site in North Carolina in an project that will also see it consolidate US distribution operations.

Lonza paper reveals secrets behind cGMP stem cell production

25-Sep-2015 - Lonza has published a guide to clinical-grade induced pluripotent stem cell (IPSC) manufacture, addressing concerns around the derivation of cellular materials.

Cobra and Manchester Uni receive grant for biologics scale-up

24-Sep-2015 - Cobra Biologics, a Swedish contract development and manufacturing organisation, has launched a project to improve scale-up of biologics with the University of Manchester, UK.

China's Ausia BioTech seeks international pharma customers

23-Sep-2015 - Hangzhou CMO Ausia BioTech has partnered with New Mexico-based PaizaBio to market its manufacturing services to Western drugmakers interested in the Chinese sterile injectables market. 

Aesica and Merck & Co. to benefit from green energy cost-savings in UK

23-Sep-2015 - Electricity from a ‘green energy’ biomass plant being built nearby will cut utility costs at an Aesica UK facility and help the CDMO stay competitive.

Vaccine-maker IDT Biologika launches in US

23-Sep-2015 - German CDMO IDT Biologika has opened its first facility in the US and will contract manufacture vaccines.

Greatbatch: $1.7bn acq 'transfromative' in the medical device space

22-Sep-2015 - Standard & Poor has assigned a ‘stable’ rating to Greatbatch after the contract manufacturer secured $1.5bn to buy fellow medical devicemaker Lake Region Medical.

Swedish engineering firm selected to design $76m Russian plasma plant

21-Sep-2015 - KeyPlants has been selected for the design and engineering of a 600,000L plasma processing facility operated by Russia’s MasterPlasma.

ShangPharma pumps $60m into Qidong biologics plant for international clients

17-Sep-2015 - China’s ShangPharma is building a $60m (€53m) single-use biologics manufacturing plant in Qidong, to be operated by its CMO subsidiary.

Baxalta shifting to biosimilar outsourced model, selling ex-Genmab MN plant

16-Sep-2015 - Baxalta will sell a Minnesota facility it acquired from Genmab in 2013 as part of a new outsourcing strategy it has adopted for biosimilar production.

Bavarian Nordic wins up to $33m to develop J&J Ebola vaccine

16-Sep-2015 - Danish biotech Bavarian Nordic has signed a $9m contract from Johnson & Johnson to improve stability of their joint Ebola vaccine. After options and milestone awards, payment could total $33m.

Abzena bolsters biologics business by buying US CDMO PacificGMP

14-Sep-2015 - Abzena has broadened its biologics services and added a Californian manufacturing facility through the acquisition of CDMO PacificGMP.

Trial supplies of candidate breast cancer radio-mAb still stable after 5 years says study

11-Sep-2015 - Trial supplies of a radio-immunotherapy drug made by Areva Med in compliance with GMP are stable five years after they were produced according to the results of new analysis.

Peregrine up on CMO Q1 sales and backlog, as new plant set to go online

10-Sep-2015 - Manufacturing backlog at Avid Bioservices has reached $42m as the firm books up space at a new facility currently undergoing its first internal pilot run.

Aragen Bioscience licenses protein yield boosting tech for cell line development

09-Sep-2015 - ProteoNic Biotechnology BV has licensed its protein production technology to US contractor Aragen Bioscience.

Lubrizol buys Particle Sciences to build in device and formulations contracting space

09-Sep-2015 - Berkshire Hathaway-owned Lubrizol has bought drug formulation and device contractor Particle Sciences.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...